Healthy aging is a multidimensional process influenced by genetic, environmental, and lifestyle factors. Preventive strategies to promote functional longevity are increasingly important as populations age. Unani medicine, rooted in humoral theory and centuries of traditional practice, offers a range of regimens aimed at supporting physiological resilience and delaying age-related decline. This review synthesizes classical Unani concepts with contemporary scientific evidence, explores their mechanistic basis, and evaluates clinical relevance for practitioners seeking integrative approaches to healthy aging.
The demographic shift toward older populations has heightened the need for effective interventions to prevent age-associated morbidity and preserve functional capacity. Unani medicine, one of the oldest holistic systems of healthcare, emphasizes preventive regimens (Ilaj-bil-Tadbeer) and lifestyle modifications to sustain health across the lifespan. By integrating these approaches with modern gerontological insights, clinicians can enhance patient outcomes through personalized, evidence-based preventive strategies.
Globally, the population aged 60 years and older is projected to double by 2050, with a concomitant rise in chronic diseases, frailty, and disability. Age-associated conditions such as cardiovascular disease, diabetes, osteoarthritis, cognitive decline, and sarcopenia significantly affect quality of life and healthcare expenditure. The World Health Organization emphasizes functional ability as the determinant of healthy aging, underscoring the importance of early preventive measures. Traditional preventive regimens, as advocated in Unani medicine, may offer adjunctive benefits in reducing the burden of geriatric syndromes when integrated with modern clinical practice.
Functional aging is characterized by cumulative cellular and molecular damage, dysregulation of homeostasis, and diminished physiological reserve. Oxidative stress, chronic inflammation, mitochondrial dysfunction, and hormonal imbalances are central to the aging process. In Unani philosophy, aging is attributed to the predominance of cold and dry temperament (Barid Yabis Mizaj) and gradual depletion of innate heat (Harrarat-e-Ghareeziya). Preventive Unani regimens aim to counteract these changes, restore humoral balance, and reinforce the body’s intrinsic reparative mechanisms through diet, lifestyle, and pharmacological measures.
Well-established risk factors for accelerated aging and functional decline include sedentary behavior, poor nutrition, psychosocial stress, comorbidities, and environmental exposures. In Unani perspectives, imbalance of humors (Akhlat), disruption of temperament (Mizaj), and impairment of organ functions (Aza) are significant contributors. Modern evidence corroborates the role of lifestyle factors—such as physical inactivity and dietary insufficiency—in mediating inflammation, metabolic dysfunction, and age-related degeneration. Addressing these risk factors through tailored preventive strategies is critical for optimizing functional aging.
Age-related functional decline manifests as sarcopenia, cognitive impairment, frailty, sensory deficits, and reduced adaptive capacity. In Unani clinical practice, early signs of maladaptive aging include sleep disturbances, appetite changes, fatigue, musculoskeletal stiffness, and diminished vitality. Early identification of these features enables timely intervention, reducing the risk of progression to more severe geriatric syndromes. Unani practitioners utilize detailed history-taking, temperament assessment, and physical examination to recognize preclinical and clinical markers of aging.
Diagnosis in Unani medicine is a comprehensive process involving assessment of Mizaj, evaluation of humoral imbalances, and identification of predisposing environmental and lifestyle factors. Clinical tools such as tongue and pulse examination, as well as quantification of functional status (e.g., mobility, cognition), are employed. Integration of conventional diagnostic modalities—including laboratory testing, imaging, and validated geriatric assessment scales—enhances diagnostic accuracy and informs the selection of appropriate preventive or therapeutic regimens.
Preventive Unani regimens for healthy aging encompass a spectrum of interventions: (1) Ilaj-bil-Tadbeer (regimenal therapy) including massage (Dalak), fomentation (Hammam), and exercise (Riyazat); (2) Ilaj-bil-Ghiza (dietary management) focusing on nutrient-dense, temperament-balancing foods; and (3) Ilaj-bil-Dawa (medicinal therapy), using herbal and mineral formulations with antioxidant, anti-inflammatory, and adaptogenic properties. Lifestyle modifications—such as regular physical activity, stress management (through aromatherapy and sleep hygiene), and social engagement—are emphasized. These multimodal strategies are tailored to individual temperament and risk profile, with regular monitoring and adjustment to maximize efficacy and minimize adverse effects.
Recent studies have investigated the molecular mechanisms underlying Unani interventions. Polyherbal formulations such as Majoon-e-Azaraqi, Jawarish-e-Amla, and Roghan-e-Badam have demonstrated antioxidant and neuroprotective effects in preclinical and clinical trials. Research on Unani massage and steam therapies suggests benefits in improving musculoskeletal health and circulation. Integrative models combining Unani regimens with evidence-based geriatric protocols are emerging, supporting synergistic effects on metabolic health, cognitive function, and quality of life. Advances in biomarker profiling and personalized medicine hold promise for refining preventive strategies and optimizing outcomes in older adults.
Leading geriatric and integrative medicine organizations advocate a holistic approach to healthy aging, including regular physical activity, balanced nutrition, cognitive engagement, and psychosocial support. Unani guidelines align with these principles, recommending individualized preventive regimens based on temperament, age, season, and comorbidities. Regular reassessment and patient education are essential to ensure adherence and address emerging health needs. Collaboration between Unani and conventional practitioners facilitates comprehensive, patient-centered care and enhances the implementation of preventive strategies in diverse clinical settings.
Preventive Unani regimens offer a scientifically plausible and clinically relevant approach to promoting healthy functional aging. Through personalized lifestyle modification, dietary management, and regimenal therapies, Unani medicine addresses both traditional and modern risk factors for age-related decline. Integration with contemporary evidence and clinical guidelines enhances the potential of these interventions to support healthy longevity. Ongoing research and interdisciplinary collaboration are essential to further elucidate mechanisms, optimize protocols, and translate preventive Unani strategies into mainstream geriatric care.
1.
Independent Risk Factors for "Deaths of Despair" Found.
2.
New imaging probe helps track prostate cancer and possibly treat it before resistance develops
3.
Proton Therapy Fails to Beat IMRT in Prostate Cancer
4.
Infection Burden High With Myeloma T-Cell Therapies
5.
PPI, Antibiotics May Curb Durvalumab Efficacy in NSCLC
1.
Genomic Control of Erythropoietic Stem Cell Renewal
2.
Case-Based Learning on Unexpected Cytopenia Patterns Following Advanced Therapies
3.
Subchorionic Hematoma: Causes, Symptoms, and Treatment
4.
Clonal Hematopoiesis as a Mechanism of Age-Related Disease
5.
Transformative Insights in Oncology in Daily Practice
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Innovations in Hematology
2.
Case-Based Learning: Oncology
3.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
4.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- The Conclusion
5.
Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation